---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001485"
form_type: "8-K"
ticker: "VSBC"
cik: "0001697884"
company_name: "VITASPRING BIOMEDICAL CO. LTD."
filed_at: "2026-09-10T17:22:10+00:00"
generated_at: "2026-09-10T17:23:41.054956+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# VitaSpring Biomedical names Jing-Zhou Chen CEO/CFO, Shao-Hsiang Shih Chairman; Lai resigns

## Summary
- Ssu-Chuan Lai resigned as Chairperson, CEO, President, CFO, Secretary, and director effective 11:58 p.m. PT Sept 7, 2026; no disagreement cited.
- Jing-Zhou Chen, 40, appointed CEO, President, CFO, and Secretary effective 11:57 p.m. PT Sept 7, 2026; no employment agreement or compensation.
- Shao-Hsiang Shih, 54, elected director and appointed Chairman of the Board effective same time; no compensation.
- Both new appointees have no family relationships or material interests; indemnification agreements authorized but not yet executed.

## SEC filing metadata
- accession: 0001640334-26-001485
- form_type: 8-K
- ticker: VSBC
- cik: 0001697884
- company_name: VITASPRING BIOMEDICAL CO. LTD.
- filed_at: 2026-09-10T17:22:10+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/0001640334-26-001485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/vsbc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001485
- JSON: https://secwatch.observer/filing/0001640334-26-001485.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001485.txt

## Key facts
- Executive change
  Shao-Hsiang Shih was appointed as Chairman of the Board at VITASPRING BIOMEDICAL CO. LTD..
  - Action: appointed
  - Role: Chairman of the Board
  source text: Effective at 11:57 p.m. Pacific Time on September 7, 2026, Mr. Shih was appointed Chairman of the Board, to serve at the pleasure of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/0001640334-26-001485-index.htm
- Executive change
  Ssu-Chuan Lai resigned as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Effective at 11:58 p.m. Pacific Time on September 7, 2026, immediately following the election of her successor as a director and the appointment of her successor officers as described in Items 5.02(c) and (d) below, Dr. Ssu-Chuan Lai resigned from her positions as Chairperson of the Board, Chief Executive Officer, President, Chief Financial Officer, and Secretary of the Company, and as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/0001640334-26-001485-index.htm
- Executive change
  Jing-Zhou Chen was appointed as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: Effective at 11:57 p.m. Pacific Time on September 7, 2026, Dr. Ssu-Chuan Lai, as the sole director then in office, appointed Jing-Zhou Chen as the Company’s Chief Executive Officer, President, Chief Financial Officer, and Secretary, to serve at the pleasure of the Board and until his successor is duly appointed and qualified, or until his earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/0001640334-26-001485-index.htm
- Executive change
  Shao-Hsiang Shih was elected as Director at VITASPRING BIOMEDICAL CO. LTD..
  - Action: elected
  - Role: Director
  source text: Effective at 11:56 p.m. Pacific Time on September 7, 2026, Ssu-Chuan Lai, as the sole director then in office, elected Shao-Hsiang Shih to serve as a director of the Company, to hold office until the next annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/0001640334-26-001485-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.